ATE319699T1 - Mannitol- und glucitolderivate - Google Patents

Mannitol- und glucitolderivate

Info

Publication number
ATE319699T1
ATE319699T1 AT03028655T AT03028655T ATE319699T1 AT E319699 T1 ATE319699 T1 AT E319699T1 AT 03028655 T AT03028655 T AT 03028655T AT 03028655 T AT03028655 T AT 03028655T AT E319699 T1 ATE319699 T1 AT E319699T1
Authority
AT
Austria
Prior art keywords
mannitol
glucitol derivatives
oligomeric compounds
glucitol
derivatives
Prior art date
Application number
AT03028655T
Other languages
English (en)
Inventor
Frank Dr Bergmann
Der Eltz Herbert Dr Von
Christoph Dr Seidel
Kurt Dr Weindel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02028714A external-priority patent/EP1431297A1/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE319699T1 publication Critical patent/ATE319699T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
AT03028655T 2002-12-20 2003-12-16 Mannitol- und glucitolderivate ATE319699T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02028714A EP1431297A1 (de) 2002-12-20 2002-12-20 Mannitol- und Glucitolderivate
US44021203P 2003-01-15 2003-01-15
EP03001215 2003-01-20

Publications (1)

Publication Number Publication Date
ATE319699T1 true ATE319699T1 (de) 2006-03-15

Family

ID=32600614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03028655T ATE319699T1 (de) 2002-12-20 2003-12-16 Mannitol- und glucitolderivate

Country Status (8)

Country Link
EP (1) EP1431298B1 (de)
JP (1) JP4169689B2 (de)
CN (1) CN1513849B (de)
AT (1) ATE319699T1 (de)
CA (1) CA2453382C (de)
DE (1) DE60303865T2 (de)
ES (1) ES2260569T3 (de)
HK (1) HK1066222A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2370450A1 (de) 2008-11-27 2011-10-05 Roche Diagnostics GmbH Gezielte synthese von oligophosphoramidatstereoisomeren
RU2015153109A (ru) 2009-09-16 2019-01-15 Дженентек, Инк. Содержащие суперспираль и/или привязку белковые комплексы и их применения
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
EP2659269B1 (de) 2010-12-23 2016-10-26 Roche Diagniostics GmbH Erkennung von posttranslational modifiziertem polypeptid durch ein bivalentes bindungsmolekül
SG191153A1 (en) 2010-12-23 2013-07-31 Hoffmann La Roche Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
CN103384681B (zh) 2010-12-23 2018-05-18 霍夫曼-拉罗奇有限公司 结合剂
KR20140127854A (ko) 2012-02-10 2014-11-04 제넨테크, 인크. 단일-쇄 항체 및 다른 이종다량체
RU2015100656A (ru) 2012-06-27 2016-08-20 Ф. Хоффманн-Ля Рош Аг Способ получения конъюгатов fc-фрагмента антитела, включающих по меньшей мере одну связывающую группировку, которая специфически связывается с мишенью, и их применения
WO2014001324A1 (en) 2012-06-27 2014-01-03 Hoffmann-La Roche Ag Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof
EP3227332B1 (de) 2014-12-03 2019-11-06 F.Hoffmann-La Roche Ag Multispezifische antikörper
US10781175B2 (en) 2016-07-15 2020-09-22 Am Chemicals Llc Solid supports and phosphoramidite building blocks for oligonucleotide conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ292140A (en) * 1994-08-17 1998-02-26 Stichting Rega V Z W Oligomers consisting of 1,5-anhydrohexitol nucleosides, antisence techniques.
DE10044373A1 (de) * 2000-09-08 2002-03-21 Roche Diagnostics Gmbh Neues Reagenz zur Markierung von Nukleinsäuren

Also Published As

Publication number Publication date
EP1431298A1 (de) 2004-06-23
CN1513849A (zh) 2004-07-21
DE60303865D1 (de) 2006-05-04
ES2260569T3 (es) 2006-11-01
JP2004203878A (ja) 2004-07-22
CA2453382A1 (en) 2004-06-20
HK1066222A1 (en) 2005-03-18
CA2453382C (en) 2009-04-07
EP1431298B1 (de) 2006-03-08
JP4169689B2 (ja) 2008-10-22
DE60303865T2 (de) 2006-09-21
CN1513849B (zh) 2013-03-27

Similar Documents

Publication Publication Date Title
DE502004010433D1 (de) Prozeß zur Herstellung von Aryl- oder Heteroarylamin-Boronsäurederivaten
ATE381552T1 (de) Derivate von 1-piperazin- und 1- homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
DK1831362T3 (da) Syreaktive svampeproteaser
NO20044290L (no) Fremgangsmate for forbedring av boredybdemalinger
ATE417127T1 (de) Nukelinsäuresequenzbestimmung mittels elektronischem nachweis
CY1111771T1 (el) Ενζυμα τα οποια εχουν δραστικοτητα αλφα αμυλασης και μεθοδοι χρησεις τους
HK1054967A1 (en) Method of amplifying nucleic acid by using double-stranded nucleic acid as template
DE602005015834D1 (de) 3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
ATE421501T1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
ATE319699T1 (de) Mannitol- und glucitolderivate
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
DE50309356D1 (de) tung von Werkstücken
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
ATE447567T1 (de) Verfahren zur herstellung von tryptase- inhibitoren
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
DE602005018474D1 (de) Nachweis von hiv-typen und hiv-subtypen
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
NO20043400L (no) Fremgangsmater for nukleinsyreamplifisering
DE60216135D1 (de) Prozess zur herstellung von organischen hydroperoxiden
DE60335766D1 (de) Verfahren zur Herstellung von m-Xylylendiamin
DE60135751D1 (de) Methode zum nachweis von nukleinsäurepolymorphismen
DE602004001646D1 (de) Verfahren zur Herstellung von Pyran

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1431298

Country of ref document: EP